{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457956777
| IUPAC_name = (±)-1-phenyl-2-(methylamino)pentan-1-one
| image = Pentedrone.svg

<!--Clinical data-->
| tradename = 
| pregnancy_category = 
| legal_status =
| legal_CA = Schedule I
| legal_US = Schedule I
| legal_UK = Class B
| legal_DE = Anlage II
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 879722-57-3
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 71750191
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 2ELU1B757Q
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID      = 26286729

<!--Chemical data-->
| C=12 | H=17 | N=1 | O=1
| molecular_weight = 191.269 g/mol
| smiles = O=C(C(CCC)NC)C1=CC=CC=C1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI          = 1S/C12H17NO/c1-3-7-11(13-2)12(14)10-8-5-4-6-9-10/h4-6,8-9,11,13H,3,7H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey       = WLIWIUNEJRETFX-UHFFFAOYSA-N
}}

'''Pentedrone''' (also known as '''α-methylamino-valerophenone''') is a [[stimulant]] of the [[Substituted cathinone|cathinone]] class that has been sold as a [[designer drug]] and has been found since 2010 as an ingredient in a number of "[[Bath salts (drug)|bath salt]]" mixes sold as [[legal high]]s.<ref>[http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf EMCDDA Annual Report 2010]</ref><ref>[http://www.drugs.ie/features/feature/research_on_head_shop_drugs_in_dublin_part_2 Research on Head Shop drugs in Dublin: Part 2]</ref><ref>[http://www.dit.ie/cser/media/ditcser/documents/Head_Report2011_overview.pdf An overview of new psychoactive substances and the outlets supplying them]</ref><ref>{{cite journal | url=http://www.fsijournal.org/article/S0379-0738%2811%2900533-0/abstract | title=Mass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-products |author1=Folker Westphall |author2=Thomas Junge |author3=Ulrich Girreser |author4=Wolfgang Greibl |author5=Carmen Doering | journal=Forensic Science International |date=April 2012  | volume=217 | issue=1-3 | pages=157–167 | doi=10.1016/j.forsciint.2011.10.045 | pmid=22115724}}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1002/dta.385/abstract | title=Chemical analysis of two new designer drugs: buphedrone and pentedrone |author1=Chad R. Maheux |author2=Catherine R. Copeland | journal=Drug Testing and Analysis |date=January 2012  | volume=4 | issue=1 | pages=17–23 | doi=10.1002/dta.385 | pmid=22113925}}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1111/1556-4029.12629/abstract | title=Analysis of the First- and Second-Generation Raving Dragon Novelty Bath Salts Containing Methylone and Pentedrone |author1=Justin L. Poklis |author2=Carl E. Wolf |author3=Omar I. ElJordi |author4=Kai Liu |author5=Shijun Zhang |author6=Alphonse Poklis | journal=Journal of Forensic Sciences |date=January 2015  | volume=60 | issue=11 | pages=234–240 | doi=10.1111/1556-4029.12629 | pmid=25470207}}</ref><ref>{{cite journal | url=http://www.fsijournal.org/article/S0379-0738%2814%2900324-7/abstract | title=Analytical profiles of "legal highs" containing cathinones available in the area of Lisbon, Portugal |author1=Victor M.R. Zancajo |author2=J. Brito |author3=Marta P. Carrasco |author4=M.R. Bronze |author5=Rui Moreira |author6=Alvaro Lopes | journal=Forensic Science International |date=November 2014  | volume=244 | pages=102–110 | doi=10.1016/j.forsciint.2014.08.010 | pmid=25240621}}</ref>

==Pharmacology==

Pentedrone acts as a [[norepinephrine-dopamine reuptake inhibitor]] without causing their [[Monoamine releasing agent|release]], the same mechanism of action as [[methylphenidate]].<ref>{{Cite journal | doi = 10.1016/j.neuropharm.2013.11.008| pmid=24275046
 | url=http://onlinelibrary.wiley.com/doi/10.1002/dta.385/abstract | title = Monoamine transporter and receptor interaction profiles of a new series of designer cathinones| journal = Neuropharmacology| volume = 79| pages = 152–60| year = 2014| last1 = Simmler | first1 = L. D. | last2 = Rickli | first2 = A.| last3 = Hoener | first3 = M. C. | last4 = Liechti | first4 = M. E. }}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1111/adb.12299/abstract | title=The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity |author1=Ji-Young Hwang |author2=Jun-Sub Kim |author3=Ji-Hwan Oh |author4=Sa-Ik Hong |author5=Shi-Xun Ma |author6=Yang-Hee Jung |author7=Yong-Hyun Ko |author8=Seok-Yong Lee |author9=Hyoung-Chun Kim |author10=Choon-Gon Jang | journal=Addiction Biology |date=August 2015  | doi=10.1111/adb.12299 | pmid=26290055}}</ref>

==Side effects==

Pentedrone has been linked to at least one death where it was combined with [[Alpha-Pyrrolidinopentiophenone|α-PVP]] and caused heart failure.<ref>{{Cite journal | doi = 10.1093/jat/bkv011| pmid=25737339 | title = A Fatal Case of Pentedrone and  -Pyrrolidinovalerophenone Poisoning| journal = Journal of Analytical Toxicology | url=http://jat.oxfordjournals.org/content/39/4/324 |date=March 2015 | volume = 39 | issue = 4 | pages =  324–329 | last1 = Sykutera | first1 = M.| last2 = Cychowska | first2 = M.| last3 = Bloch-Boguslawska | first3 = E.}}</ref>

==Detection==
A forensic standard of Pentedrone is available, and the compound has been posted on the Forendex website of potential drugs of abuse.<ref>{{cite web | url=http://forendex.southernforensic.org/index.php/detail/index/1164 | title=Pentedrone | publisher=Southern Association of Forensic Scientists | accessdate=8 September 2015}}</ref>

==Legal status==

On January 28, 2014, the DEA listed it, along with 9 other synthetic cathinones, on the Schedule 1 with a temporary ban, effective February 27, 2014.<ref name="temp schedule notice">{{cite web|url=http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0128.htm|date=28 January 2014|title=Temporary Placement of 10 Synthetic Cathinones into Schedule I}}</ref>

Pentedrone is a [[Drugs controlled by the German Betäubungsmittelgesetz|Anlage II]] controlled drug in Germany.

As of October 2015 Pentedrone is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

Pentedrone is banned in the Czech Republic.<ref>{{cite web | url=http://www.mzcr.cz/Admin/_upload/files/3/Nov%C3%A9%20PL.pdf | title=Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení  vlády č. 463/2013 Sb.) | publisher=Ministerstvo zdravotnictví | language=Czech}}</ref>

==See also==
* [[4-Methylpentedrone]]
* [[Buphedrone]]
* [[MDPV]]
* [[Methcathinone]]
* [[Pentylone]]
* [[Substituted cathinone]]

== References ==
{{Reflist}}

{{Stimulants}}
{{Phenethylamines}}

[[Category:Cathinones]]
[[Category:Designer drugs]]
[[Category:Norepinephrine-dopamine reuptake inhibitors]]


{{nervous-system-drug-stub}}